Skip to main content

Pardes Biosciences, Inc.

PRDSDelisted Aug 31, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001822711

Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.

Holders of 5% or more of PRDS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pardes Biosciences, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Pardes Biosciences, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Pardes Biosciences, Inc., newest first.

No Schedule 13D or 13G filings on Pardes Biosciences, Inc. are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Pardes Biosciences, Inc. shares.

No Form 144 notices for Pardes Biosciences, Inc. are on file.